Back to Search
Start Over
Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases: A Phase 0/I Study.
- Source :
- Clinical Nuclear Medicine; Jun2023, Vol. 48 Issue 6, p489-496, 8p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 03639762
- Volume :
- 48
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Clinical Nuclear Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 163487037
- Full Text :
- https://doi.org/10.1097/RLU.0000000000004634